Erik Manting

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erik Manting:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Director Stock Option (right to buy) 70K 14 Jun 2024 Direct

Insider Reports Filed by Erik Manting

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAZ Transcode Therapeutics, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:16
RNAZ Transcode Therapeutics, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 20:09
RNAZ Transcode Therapeutics, Inc. 10 May 2023 1 $0 4 Director 10 May 2023, 18:13
RNAZ Transcode Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 22 Jun 2022, 20:24
RNAZ Transcode Therapeutics, Inc. 08 Jul 2021 0 $0 3 Director 08 Jul 2021, 21:53